TMO Institutional & Insider Stock Sell-Offs Upset Market: How to Play
Portfolio Pulse from
Thermo Fisher Scientific (TMO) is experiencing a sell-off by institutional and insider investors, causing market concerns. The decline in COVID testing-related demand is leading to a decrease in testing revenues, further impacting the stock.
December 11, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Thermo Fisher Scientific is facing a sell-off by institutional and insider investors, alongside a decline in testing revenues due to reduced COVID testing demand.
The sell-off by institutional and insider investors indicates a lack of confidence in the stock, which is compounded by declining revenues from COVID testing. This is likely to negatively impact TMO's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100